An AI-based, device-agnostic ECG signal processing and Holter reporting software sold to cardiac clinics, Holter labs, and ECG device manufacturers. The platform increases ECG throughput without additional staff or hardware and is approaching FDA clearance.
- Cardiac clinics face bottlenecks in ECG and Holter interpretation
- AI automation increases throughput without adding headcount
- Device-agnostic design integrates with existing hardware
- Long-form ECG analysis completed in minutes instead of hours
- Software supports repeat usage and long-term contracts
New. The technology is approaching FDA clearance and has been validated by cardiologists and clinical workflows.
- Introduce the platform to cardiac clinics and Holter labs
- Position throughput gains and workflow efficiency
- Engage ECG device manufacturers for OEM or integration use
- Support evaluations and pilot discussions
- Close software or partnership agreements
- Technical documentation and clinical positioning materials
- Device-agnostic integration support
- Physician-validated use cases and testimonials
- Partner program with tracking and attribution
- Direct access to the technical and leadership team
- Independent reps with medical, diagnostics, or device sales experience
- Reps already calling on cardiology clinics or cardiac labs
- Comfortable selling regulated clinical software
- Consultative sellers who manage longer sales cycles
- Red flag: expects fast transactional or low-complexity deals
- Validated by practicing cardiologists
- Demonstrated accuracy rivaling expert human interpretation
- Designed for clinical-grade ECG and Holter workflows
- Is this hardware-dependent? No, fully device-agnostic
- Who is the buyer? Cardiac clinics, Holter labs, and device manufacturers
- Is this recurring revenue? Yes, software and usage-based contracts
- Is FDA clearance required? Clearance is in progress